4.4 Article

Metabolic control of antifungal drug resistance

Journal

FUNGAL GENETICS AND BIOLOGY
Volume 47, Issue 2, Pages 81-93

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.fgb.2009.07.004

Keywords

Antifungal drug resistance; Saccharomyces cerevisiae; Candida albicans; Azole; Hsp90; Calcineurin; Tor; Threonine; Nutrient signaling; Erg3

Funding

  1. Natural Sciences and Engineering Research Council of Canada
  2. Burroughs Wellcome Fund
  3. Canada Research Chair in Microbial Genomics and Infectious Disease
  4. Canadian Institutes of Health Research [MOP-86452]

Ask authors/readers for more resources

Fungi have evolved an elegant repertoire of mechanisms to survive the cellular stress exerted by antifungal drugs such as azoles, which inhibit ergosterol biosynthesis inducing cell membrane stress. The evolution and maintenance of diverse resistance phenotypes is contingent upon cellular circuitry regulated by the molecular chaperone Hsp90 and its client protein calcineurin. Here, we establish a novel role for nutrients and nutrient signaling in azole resistance. The vulnerability of Saccharomyces cerevisiae azole resistance phenotypes to perturbation was contingent upon specific auxotrophies. Using strains that acquired azole resistance by Erg3 loss of function as a model for resistance that depends on cellular stress responses, we delineated genetic and environmental factors that mitigate the translation of genotype into resistance phenotype. Compromising a global regulator that couples growth and metabolism to environmental cues, Tor kinase, provides a powerful strategy to abrogate drug resistance of S. cerevisiae and Candida albicans with broad therapeutic potential. (c) 2009 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available